AVET PHARMA ANNOUNCES A CLASS SETTLEMENT WITH THE END PAYER PLAINTIFFS IN GENERIC PHARMACEUTICALS PRICING ANTITRUST LITIGATION

EAST BRUNSWICK, N.J., June 13, 2024 /PRNewswire/ — Avet Pharmaceuticals Inc. (“Avet”), formerly known as Heritage Pharmaceuticals Inc., announced today that the Company has entered into a settlement agreement with a putative class of End Payer Plaintiffs (the “EPP Class Plaintiffs”) in…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.